Cryptococcal meningitis in patient with X-linked hyper-IgM1 syndrome

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 6-7, 2005, Pages 526-528

  de Górgolas, Miguel ^a   Erice, Alejo ^b   Gil, Antonio ^c   Gutiérrez, Javier ^b   Rivas, Pablo ^a   Hernando, Carlos ^b   García Rodríguez, Ma Cruz ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b ASEPEYO   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B DEOXYCHOLATE; CEFTRIAXONE; COTRIMOXAZOLE; FLUCONAZOLE; IMMUNOGLOBULIN; INDIAN INK; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; CELLULAR IMMUNODEFICIENCY; CEREBROSPINAL FLUID ANALYSIS; CHEMOPROPHYLAXIS; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; FUNGAL MENINGITIS; GASTROINTESTINAL INFECTION; HEAD INJURY; HERPES; HUMAN; HYPERIMMUNOGLOBULINEMIA M; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; RESPIRATORY TRACT INFECTION; SECONDARY PREVENTION; SUPERINFECTION; X CHROMOSOME LINKED DISORDER;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEOXYCHOLIC ACID; DRUG COMBINATIONS; FLUCONAZOLE; GENETIC DISEASES, X-LINKED; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN M; MALE; MENINGITIS, CRYPTOCOCCAL;

EID: 22844449070     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540510036570     Document Type: Article

References (13)

1. Rosen FS, Cooper MD, Wedgwood RJP. The primary immunodeficiencies. N Engl J Med 1995;333:431-8.
2. Notarangelo ID, Hayward R. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120: 399-405.
3. Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W. Defects of T-cell effector function and postthymic maturation in X-linked hyper-IgM syndrome. J Clin Invest 1999;103:1151-8.
4. Levy J, Español-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatrics 1997;131:47-54.
5. Iseki M, Anzo M, Yamashita N, Matsuo N. Hyper-IgM immunodeficiency with disseminated cryptococcosis. Acta Pediatrica 1994;83:780-2.
6. Jo E-K, Kim H-S, Lee MY, Iseki M, Lee J-H, Song C-H, et al. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformanas infections: the first case with molecular diagnosis in Korea. J Korean Med Sci 2002;17:116-20.
7. López-Granados E, Cambronero R, Ferreira A, Fontán G, MC García-Rodríguez MC. Three novel mutations reflect the variety of defects Causing phenotypically diverse X-linked hyper-IgM syndrome. Clin Exp Immunol 2003;133:123-31.
8. Leiva LE, Junprasert J, Hollenbaugh D, Sorensen RU. Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T-cells in a patient with hyper-IgM syndrome. J Clin Immunol 1998;18:283-90.
9. Cunningham CK, Bonville CA, Ochs HD, Seyama K, John PA, Rotbart HA, et al. Enteroviral meningoencephalitis 9 as a complication of X-linked hyper-IgM syndrome. J Pediat 1999;134:584-8.
10. Tabone MD, Leverger G, Landman J, Aznar C, Bucon-Gibod L, Lasfargues G. Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency. Pediatr Infect Dis J 1994;13:77-9.
11. Duplantier JE, Seyama K, Day NK, Hitchcock R, Nelson RP Jr, Ochs HD, et al. Immunological reconstitution following bone marrow transplantation for X-linked hyper-IgM syndrome. Clin Immunol 2001;98:313-8.
12. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-9.
13. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. Q J Med 2000;93:245-51.